Pfizer celebrates UK Viagra switch
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Men in the UK will soon have OTC access to Pfizer’s blockbuster erectiledysfunction treatment Viagra after an application to switch the sildenafil-based product was given the green light.
You may also be interested in...
Why Did Germany Reject Sildenafil OTC Switch?
Sildenafil was rejected at Germany’s independent switch committee’s most recent meeting. HBW Insight examines some of the arguments for and against the switch put forward by the regulator, members of the committee and the applicant, as recorded in the recently published minutes.
OTC Marketing Awards 2019 Winners Announced – GSK Crowned Company Of The Year, Pfizer’s Viagra Takes Best Brand
GSK, Pfizer, HRA Pharma and Mentholatum all enjoyed a particularly fruitful evening at the OTC Marketing Awards 2019. J&J, P&G and RB were also among the winners at a celebration of the best and brightest in the UK consumer health market.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.